Immuno-allertypes in non-cystic fibrosis  bronchiectasis

P. Tiew (singapore, Singapore), M. Mac Aogain (singapore, Singapore), A. Lim (singapore, Singapore), T. Low (singapore, Singapore), G. Tan (singapore, Singapore), T. Hassan (Kuala Lumpur, Malaysia), T. Ong (singapore, Singapore), S. Pang (singapore, Singapore), Z. Lee (singapore, Singapore), X. Gwee (singapore, Singapore), C. Martinus (singapore, Singapore), Y. Sio (singapore, Singapore), A. Matta (singapore, Singapore), T. Ong (singapore, Singapore), L. Tiong (singapore, Singapore), K. Wong (singapore, Singapore), S. Narayanan (singapore, Singapore), V. Au (singapore, Singapore), D. Marlier (singapore, Singapore), H. Keir (Dundee, United Kingdom), J. Abisheganaden (singapore, Singapore), M. Koh (singapore, Singapore), D. Wang (singapore, Singapore), J. Connolly (singapore, Singapore), F. Chew (singapore, Singapore), J. Chalmers (Dundee, United Kingdom), S. Chotirmall (singapore, Singapore)

Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session: Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session type: Thematic Poster
Number: 1142
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Tiew (singapore, Singapore), M. Mac Aogain (singapore, Singapore), A. Lim (singapore, Singapore), T. Low (singapore, Singapore), G. Tan (singapore, Singapore), T. Hassan (Kuala Lumpur, Malaysia), T. Ong (singapore, Singapore), S. Pang (singapore, Singapore), Z. Lee (singapore, Singapore), X. Gwee (singapore, Singapore), C. Martinus (singapore, Singapore), Y. Sio (singapore, Singapore), A. Matta (singapore, Singapore), T. Ong (singapore, Singapore), L. Tiong (singapore, Singapore), K. Wong (singapore, Singapore), S. Narayanan (singapore, Singapore), V. Au (singapore, Singapore), D. Marlier (singapore, Singapore), H. Keir (Dundee, United Kingdom), J. Abisheganaden (singapore, Singapore), M. Koh (singapore, Singapore), D. Wang (singapore, Singapore), J. Connolly (singapore, Singapore), F. Chew (singapore, Singapore), J. Chalmers (Dundee, United Kingdom), S. Chotirmall (singapore, Singapore). Immuno-allertypes in non-cystic fibrosis  bronchiectasis. 1142

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 181-198
Year: 2017


Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 38-57
Year: 2017


Non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019


Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021


Cystic fibrosis fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

The pulmonary microbiome in non-cystic fibrosis bronchiectasis.
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

NTM in cystic fibrosis and non-CF bronchiectasis
Source: ERS Course 2015
Year: 2015

Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018


The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019


Non-tuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019


Management and prevention of non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – PG9 Lower respiratory tract infection in children
Year: 2015




Neomacrolides in cystic fibrosis
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012


Non-cystic fibrosis bronchiectasis: series of 89 patients
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Changing characteristics of childhood non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011

HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Immunodeficits in bronchiectasis
Source: International Congress 2017 – PG3 Bronchiectasis
Year: 2017